D-dimer: A biomarker for antihistamine-resistant chronic urticaria

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
What drives prescription patterns in pediatric asthma management?
Allergen immunotherapy: A practice parameter third update
Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria  Riccardo Asero, MD, Alberto Tedeschi, MD, Raffaella Coppola,
Alexandra Kazaks, MA, RD, Janet Y. Uriu-Adams, PhD, Judith S
Fatty acids, inflammation, and asthma
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Atopic dermatitis: Age and race do matter!
Dennis K. Ledford, MD, Sally Wenzel, MD 
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Shyam Joshi, MD, David A. Khan, MD 
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Fatty acids, inflammation, and asthma
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Rising prevalence of asthma is sex-specific in a US farming population
Keith J. Simons, PhD, Margherita Strolin Benedetti, PhD, F. Estelle R
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor–associated angioedema 
Treatment of chronic autoimmune urticaria with omalizumab
Peter M. Wolfgram, MD, David B. Allen, MD 
Etiology of asthma exacerbations
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug–related urticaria and angioedema  Marek L.
Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2  Phillip Lieberman, MD  The Journal of Allergy.
Reply Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, Michael Tankersley, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
News & Notes Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, David Golden, MD 
Ovalbumin content of influenza vaccines
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Effect of ingested H1 antihistamines on methacholine challenge
Sharon Seth, MD, David A. Khan, MD 
What is an “eosinophilic phenotype” of asthma?
Cephalosporin Side Chain Cross-reactivity
Medication use in children with asthma in Finland from 1995 to 2006
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Personalized asthma therapy in blacks—the role of genetic ancestry
Autophagy: Nobel Prize 2016 and allergy and asthma research
News & Notes Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Alexandra Kazaks, MA, RD, Janet Y. Uriu-Adams, PhD, Judith S
New pathways for itching in patients with atopic dermatitis?
Prevention of food allergy: Beyond peanut
One step forward, 2 steps back: The enigma of preschool wheeze
Risk of oral food challenges
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Reply Journal of Allergy and Clinical Immunology
Thunderstorm-related asthma attacks
Pınar Uysal, MD, Esben Eller, MSc, PhD, Charlotte G
Measles and immunomodulation
The Editors' Choice Journal of Allergy and Clinical Immunology
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria  Sridharan Soundararajan, PhD, Yoko Kikuchi, DVM, Kusumam Joseph, PhD,
Environmental factors and eosinophilic esophagitis
News & Notes Journal of Allergy and Clinical Immunology
Advances in pediatric asthma in 2007
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Safety and efficacy of repeated monthly carboplatin desensitization
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Itching as a systemic disease
Presentation transcript:

D-dimer: A biomarker for antihistamine-resistant chronic urticaria Riccardo Asero, MD  Journal of Allergy and Clinical Immunology  Volume 132, Issue 4, Pages 983-986 (October 2013) DOI: 10.1016/j.jaci.2013.04.037 Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Proportion of patients with CU showing elevated D-dimer plasma levels as a function of clinical response to cetirizine. x-axis: 1, excellent; 2, good; 3, partial; 4, poor; 5, no response to the drug. Journal of Allergy and Clinical Immunology 2013 132, 983-986DOI: (10.1016/j.jaci.2013.04.037) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Individual levels of D-dimer in patients showing CU of different severity. Journal of Allergy and Clinical Immunology 2013 132, 983-986DOI: (10.1016/j.jaci.2013.04.037) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions